Atezolizumab + Cabozantinib in Patients w/ Metastatic, Refractory Pancreatic Cancer

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Atezolizumab + Cabozantinib in Patients w/ Metastatic, Refractory Pancreatic Cancer	Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, endocrine system disorder, malignant endocrine neoplasm, malignant pancreatic neoplasm, neoplasm, pancreas disorder, pancreatic neoplasm	Active, not recruiting	Phase 2	2026-09-11		NCT04820179

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
University of Arizona	138

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
University of Arizona Cancer Center	Tucson	United States	13

Clinical trials